Status:
NOT_YET_RECRUITING
Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum
Lead Sponsor:
Sichuan University
Conditions:
Laparoscopic Hepatectomy
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
Patients meeting enrollment criteria will be randomized 1:1 to either the dobutamine or the control group. In the dobutamine group, 3\~6μg/kg/min dobutamine will be injected intravenously after anesth...
Detailed Description
Patients meeting enrollment criteria will be randomized 1:1 to either the dobutamine or the control group. Dobutamine group: 3\~6μg/kg/min dobutamine will be injected intravenously after anesthesia i...
Eligibility Criteria
Inclusion
- undergo laparoscopic partial liver resection at West China Hospital from February 2024 to April 2024
- aged 18 to 65 years
- BMI\<30kg/m2
- liver function Child-pugh grade A to B
- American Society of Anesthesiologists（ASA）grade Ⅰto Ⅲ.
Exclusion
- coronary heart disease
- heart valvular disease
- arrhythmia
- stroke history
- cirrhosis
- esophageal varices
- esophageal disease, stomach disease, previous esophageal or gastric surgery history
- chronic kidney disease
- coagulation dysfunction.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 7 2024
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT06210217
Start Date
February 1 2024
End Date
April 7 2024
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital
Chengdu, Sichuan, China, 610041